Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Methods Mol Biol. 2022;2393:773-796. doi: 10.1007/978-1-0716-1803-5_41.
Gold nanoparticles (AuNP) are well-established contrast agents in computed tomography (CT) and photoacoustic imaging (PAI). A wide variety of AuNP sizes, shapes, and coatings have been reported for these applications. However, for clinical translation, AuNP should be excretable to avoid long-term accumulation and possible side effects. Sub-5 nm AuNP have the benefit to be excretable through kidney filtration, therefore their loading in biodegradable nanogels holds promise to result in contrast agents that have long circulation times in the vasculature and subsequent biodegradation for excretion. Polyphosphazenes are intrinsically biodegradable polymers capable of forming nanogels with high payloads, and to release their payloads upon degradation. The significant development in polyphosphazenes that have tailored degradation kinetics, and their formulation with drugs or contrast agents, has shown potential as a biodegradable platform for imaging vasculature and endogenous molecules, by combination of CT and PA modalities. Therefore, we herein present methods for the formulation of AuNP assemblies loaded in nanogels composed of biodegradable polyphosphazenes, with a size range from 50 to 200 nm. We describe protocols for their characterization by UV-vis spectroscopy, Fourier-transform infrared spectroscopy, various microscopy techniques, elemental quantification by induced coupling plasma optical emission spectroscopy and contrast production in both CT and PAI. Finally, we detail the methods to investigate their effect on cells, distribution in cells and imaging properties for detection of endogenous molecules.
金纳米颗粒 (AuNP) 是计算机断层扫描 (CT) 和光声成像 (PAI) 中成熟的对比剂。为这些应用已经报道了各种尺寸、形状和涂层的 AuNP。然而,为了临床转化,AuNP 应该是可排泄的,以避免长期积累和可能的副作用。亚 5nm 的 AuNP 具有通过肾脏过滤排泄的优点,因此它们在可生物降解纳米凝胶中的负载有望产生在血管中具有长循环时间并随后生物降解排泄的对比剂。聚膦嗪是固有可生物降解的聚合物,能够形成具有高载药量的纳米凝胶,并在降解时释放其载药量。聚膦嗪在定制降解动力学方面的显著发展,以及它们与药物或对比剂的制剂,已显示出作为一种可生物降解的平台的潜力,用于通过 CT 和 PA 模式组合成像血管和内源性分子。因此,我们在此介绍了将 AuNP 组装体负载在由可生物降解的聚膦嗪组成的纳米凝胶中的方法,纳米凝胶的尺寸范围为 50 至 200nm。我们描述了通过紫外可见光谱、傅里叶变换红外光谱、各种显微镜技术、电感耦合等离子体发射光谱的元素定量以及 CT 和 PAI 中的对比生产来对其进行表征的方案。最后,我们详细介绍了研究它们对细胞的影响、在细胞中的分布以及用于检测内源性分子的成像特性的方法。